Ginger (Zingiber officinale): An alternative for the prevention of postoperative nausea and vomiting. A meta-analysis
Graphical abstract
Introduction
Postoperative nausea and vomiting (PONV) is one of the most common complications in patients undergoing surgeries. In the postoperative setting patients may find PONV more distressing than postoperative pain (ASPAN'S evidence-based clinical practice guideline for the prevention and/or management of PONV/PDNV, 2006). PONV can lead to several secondary complications such as aspiration pneumonia, wound disruption, gastric herniation, dehydration and fatigue; therefore, it can elongate the time to recovery and increase care costs (Cao et al., 2017). The incidence of PONV and the intensity of symptoms may vary depending on several factors (Horn et al., 2014), including patient characteristics (e.g. gender, age, previous history of PONV or motion sickness) and surgical factors (e.g. type of surgery, length of anaesthesia, use of postoperative opioids) (Gan et al., 2014).
PONV is triggered by several receptor systems, thus preventing and treating PONV is a complex task. Dopamin (D2) antagonists (e.g. prochlorperazine, metoclopramide), serotonin 5-HT3 antagonists (e.g. ondansetron, granisetron), anticholinergics (scopolamine), antihistamines (H1 antagonists, e.g. dimenhydrinate) and neurokinin-1 (NK1) receptor antagonists (aprepitant, rolapitant) are recommended to alleviate PONV symptoms (Kovac, 2013). The use of these drugs is often limited by their side effects (e.g. in case of antihistamines, 5-HT3 antagonists) or availability (NK-1 receptor antagonists) (Hu et al., 2015, Toyoda et al., 2013, Fero et al., 2011). As the effectiveness of an antiemetic drug may be affected by the patient's characteristics, there is no gold standard for the treatment of PONV. Moreover, a modern antiemetic drug with negligible side-effects such as NK-1 receptor antagonists may not be available or affordable for all patients.
Ginger, an easily accessible plant in many Asian countries, has been traditionally used in the treatment of gastrointestinal disorders since ancient times (Sheikhi et al., 2015). Nowadays, it is still considered as an alternative therapy for nausea and vomiting (Sharifi-Rad et al., 2017). Ginger and its bioactive secondary metabolites, especially gingerols and shogaols interact with the 5-HT3 signalling pathway (Semwal et al., 2015). Moreover, ginger is reported to show anticholinergic and antihistaminergic activities in vitro, which may further contribute to its antiemetic effect (Abdel-Aziz et al., 2006, Pertz et al., 2011).
According to the European Medicines Agency's HMPC monograph, the use of ginger medicines containing 1–2 g of ginger per dose is based on their ‘well-established use’ for the treatment of nausea and vomiting in motion sickness (European Union herbal monograph on Zingiber officinale Roscoe, rhizoma EMA/HMPC/296,580/2012, 2012). Ginger is considered to be generally safe, but it should not be recommended for pregnant women because of its in vitro mutagenic effects (Srinivasan, 2017, Nagabhushan et al., 1987, Nakamura and Yamamoto, 1983). Upon consuming ginger medications, mild to moderate gastrointestinal side effects and sleepiness are reported to occur as the most common adverse effects (Assessment report on Zingiber officinale Roscoe, rhizoma EMA/HMPC/577856/2010). No serious adverse events have not been reported; therefore, the relative safety of ginger products could be a major benefit in therapy (Sharifi-Rad et al., 2017).
Recently, several RCTs have been conducted to evaluate the effectiveness of ginger in postoperative nausea and vomiting. The last systematic review on this topic was published more than twelve years ago (Chaiyakunapruk et al., 2006). Therefore, the aim of the present meta-analysis was to synthesize the published evidence, and evaluate the antiemetic efficacy of ginger in the postoperative setting.
Section snippets
Methods
The following PICO (patients, intervention, comparison, outcome) format was applied: P: postoperative patients; I: pharmacological doses of ginger given per os; C: placebo; and O: postoperative nausea and/or vomiting. The meta-analysis was performed using the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-Protocol). The meta-analysis protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 21th April 2017
Literature search and study selection
Using the search terms ginger and nausea for the literature search of EMBASE, PubMed, the Cochrane Central Register of Controlled Trials and Web of Science databases, and removing duplicate results, the search yielded a total of 835 potentially relevant reports. One additional report (Janngam, 2003) was identified through screening the reference lists of the previous meta-analysis of this topic (Chaiyakunapruk et al., 2006). The RCTs to be included in the meta-analysis were selected according
Discussion
Ginger has been used to ameliorate gastrointestinal disorders (e.g. nausea, vomiting, diarrhoea, etc.) since ancient times (Sheikhi et al., 2015). Nowadays, ginger is used as a complementary herbal medicine for the treatment of postoperative nausea and vomiting (Sharifi-Rad et al., 2017). The present meta-analysis was designed to synthesize the available evidence for this use. Ten RCTs were identified in the literature, which included nearly 1000 postoperative patients, and led to mixed
Conclusions
Although ginger is safe and is generally better tolerated than synthetic medications for PONV, the scientific evidence supporting its use as a herbal medicine for the treatment of PONV is still limited. Our meta-analysis supports that ginger decreases the severity of PONV, and suggests that at higher doses (≥1000 mg) it may also reduce the incidence of postoperative nausea and vomiting, and thus the demand for a rescue antiemetic agent. According to literature data, higher doses of ginger
Acknowledgements
The authors thank Dora Bokor, PharmD, for proof-reading the manuscript.
Conflicts of interest
The authors declare no conflicts of interest.
Funding
This study was supported by an Economic Development and Innovation Operative Programme Grant (GINOP 2.3.2-15-2016-00048 to P.H.) from the National Research, Development and Innovation Office, the János Bolyai Research Scholarship from the Hungarian Academy of Sciences (to D.C.), and a research grant (115796) from the National Research, Development and Innovation Office (to D.C.). TL was supported by the European Union and the State of Hungary, co-financed by the European Social Fund within the
References (49)
- et al.
Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum
Eur. J. Pharmacol.
(2006) - et al.
Investigating the effects of inhaling ginger essence on post-nephrectomy nausea and vomiting
Complement. Ther. Med.
(2015) - et al.
The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis
Am. J .Obstet. Gynecol.
(2006) A trial of a mixture of three essential oils in the treatment of postoperative nausea and vomiting
Int. J. Aromather.
(2006)- et al.
Meta-analysis in clinical trials
Control. Clin. Trials.
(1986) - et al.
Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting
Eur. J. Pharmacol.
(2014) - et al.
Why are second-generation H1-antihistamines minimally sedating?
Eur J Pharmacol.
(2015) - et al.
Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients
Eur. J. Obstet. Gynecol. Reprod. Biol.
(2013) - et al.
Mutagenicity of gingerol and shogaol and antimutagenicity of zingerone in Salmonella/microsome assay
Cancer Lett
(1987) - et al.
The active part of the [6]-gingerol molecule in mutagenesis
Mutat. Res.
(1983)
Gingerols and shogaols: important nutraceutical principles from ginger
Phytochemistry
Ginger rhizomes (Zingiber officinale): a spice with multiple health beneficial potentials
PharmaNutrition
ASPAN'S evidence-based clinical practice guideline for the prevention and/or management of PONV/PDNV
J. Perianesth. Nurs.
Effectiveness of ginger for prevention of nausea and vomiting after gynecological laparoscopy
J. Med. Assoc. Thail
A double-blind randomized controlled trial of ginger for the prevention of postoperative nausea and vomiting
Anaesth. Intensive Care
Ginger root-a new antiemetic. The effect of ginger root on postoperative nausea and vomiting after major gynaecological surgery
Anaesthesia
Assessment of postoperative nausea using a visual analogue scale
Acta Anaesthesiol. Scand.
An update on the management of postoperative nausea and vomiting
J. Anesth.
The combination of estimates from different experiments
Biometrics
Ginger does not prevent postoperative nausea and vomiting after laparoscopic surgery
Anesth. Analg.
Bias in meta-analysis detected by a simple, graphical test
BMJ
Pharmacologic management of postoperative nausea and vomiting
Expert Opin. Pharmacother.
Cited by (38)
Ginger (Zingiber officinale Roscoe) preparations for prophylaxis of postoperative nausea and vomiting: A Bayesian network meta-analysis
2023, Journal of Ethnopharmacology[6]-Gingerol: A narrative review of its beneficial effect on human health
2022, Food Chemistry AdvancesThe Effect of Ginger on Postoperative Nausea and Vomiting Among Patients Undergoing Upper and Lower Limb Surgery: A Randomized Controlled Trial
2022, Journal of Perianesthesia NursingEffects of standardized [6]-gingerol extracts and [6]-gingerol on isolated ileum and lower esophageal sphincter contractions in mice
2022, Food ChemistryCitation Excerpt :Ginger (Zingiber officinale Roscoe, Zingiberaceae) rhizomes have been used in Chinese and Thai traditional remedies for the treatment of gastrointestinal diseases, such as dyspepsia, bloating, belching, indigestion, gastritis, epigastric discomfort, gastric ulcerations, nausea, and vomiting (Giacosa et al., 2015; Nikkhah Bodagh, Maleki, & Hekmatdoost, 2019). Recently, evidence from different sources had indicated that ginger powder is safe and beneficial in relieving nausea and vomiting symptoms in various situations, such as those due to chemotherapy, pregnancy, and postoperation (Ding, Leach, & Bradley, 2013; Tóth et al., 2018; Crichton, Marshall, Marx, McCarthy, & Isenring, 2019). Nonetheless, there is still some controversy, especially with the findings about clinical studies due to the use of non-standardized ginger preparations.
The preventive and relieving effects of ginger on postoperative nausea and vomiting: A systematic review and meta-analysis of randomized controlled trials
2022, International Journal of Nursing StudiesCitation Excerpt :However, in another article (Ernst and Pittler, 2000), the authors found that taking 1 g of ginger before surgery did not have a significant effect on postoperative nausea, so more trials are needed to determine the effective dose of ginger. Although Tóth et al. (2018) found that ginger could reduce the severity and incidence of postoperative nausea and vomiting compared with placebo, the effect was not statistically significant in our study. The reason may be that we distinguished nausea and vomiting and found ginger can reduce the nausea score but not the number of vomiting episodes, so no statistically significant difference was found in the incidence of postoperative nausea and vomiting.